Conference Coverage VIVA 2022 See All Content See past conferences October 31, 2022 November 03, 2022 News Conference News VIVA 2022 TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years Longer follow-up is needed to ensure the next-generation device is as effective and safe as the standard higher-dose DCB. @TCTMD Follow Us
News Conference News VIVA 2022 TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years Longer follow-up is needed to ensure the next-generation device is as effective and safe as the standard higher-dose DCB.